 |
市场调查报告书
商品编码
1705790
全球更年期治疗市场按治疗类型、给药途径、剂型、适应症、通路和地区划分Global Menopause Treatment Market, By Treatment Type, By Route of Administration, By Form, By Indication, By Distribution Channel, By Geography |
||||||
价格
简介目录
预计 2025 年全球更年期治疗市场规模为 152.3 亿美元，到 2032 年将达到 230.5 亿美元，2025 年至 2032 年的复合年增长率为 6.1%。
| 报告范围 | 报告详细信息 | ||
|---|---|---|---|
| 基准年 | 2024 | 2025年的市场规模 | 152.3亿美元 |
| 效能数据 | 从2020年到2024年 | 预测期 | 2025年至2032年 |
| 预测期：2025-2032年复合年增长率： | 6.10% | 2032年价值预测 | 230.5亿美元 |
数字。 2025年全球市场占有率（%）
闭经是自然的生物过程，通常发生在45至55岁之间的女性身上。更年期标誌着女性生育年龄的结束和生育后生活的过渡。更年期最常见的征兆和症状包括月经不规则、潮热、盗汗、阴道干燥、情绪变化和睡眠困难。随着女性进入更年期，其雌激素水平会急剧下降。因此，控制这段过渡时期的症状是许多女性的首要任务。全球更年期治疗市场为遭受更年期症状困扰的女性提供了各种治疗选择。
市场动态：
由于生活方式的改变和健康意识的增强，女性更年期症状的盛行率不断上升，这是推动全球更年期治疗市场成长的主要因素。大量调查显示，大约四分之一的40至60岁女性表示经历过至少一种与更年期相关的问题症状。久坐工作的出现和缺乏身体活动也会增加闭经的风险。此外，大型製药企业核准和推出的新产品正在扩大治疗更年期血管舒缩症状的治疗选择。然而，荷尔蒙补充疗法的副作用和替代治疗方案的可用性仍然在一定程度上限制了市场潜力。此外，开发中国家对这种治疗方法缺乏认识也为市场相关人员带来了挑战。然而，亚太地区更年期护理技术的进步和日益增长的医疗旅游业预计将在未来几年为相关人员提供丰厚的机会。
本研究的主要特点
- 本报告对全球更年期治疗市场进行了详细分析，并以 2024 年为基准年，给出了预测期（2025-2032 年）的市场规模和年复合成长率(CAGR)。
- 它还揭示了不同领域的潜在收益成长机会，并说明了该市场的引人注目的投资提案矩阵。
- 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
- 全球更年期治疗市场的主要企业根据公司亮点、产品系列、关键亮点、财务表现和策略等参数进行分析。
- 本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
- 全球更年期治疗市场报告涉及该行业的各个相关人员，例如投资者、供应商、产品製造商、经销商、新进入者和金融分析师。
- 相关人员可以透过用于分析全球更年期治疗市场的各种策略矩阵来促进他们的决策。
目录
第一章 调查目的与前提条件
- 研究目标
- 先决条件
- 简称
第二章 市场展望
- 报告描述
- 市场定义和范围
- 执行摘要
- Coherent Opportunity Map（COM）
第三章市场动态、法规与趋势分析
- 市场动态
- 新产品发布
- 人口老化加剧
- 透过赠款资助和投资提供财政支持
- 影响分析
- 主要亮点
- 市场趋势
- PEST分析
- 监管情景
- 合併、收购和合作
- 主要提供的服务
- 治疗成本分析
- 识别顶级市场参与者
- 政府措施和投资
- 品牌映射和定价分析
- 各国医疗保健支出
4. 全球更年期治疗市场-冠状病毒（COVID-19）大流行的影响
- COVID-19流行病学
- 供需侧分析
- 经济影响
5. 2020 年至 2032 年全球更年期治疗市场（依治疗类型划分）
- 荷尔蒙疗法
- 雌激素类药物
- 黄体素
- 合併用药（雌激素和黄体素、雌激素和另一种药物）
- 非荷尔蒙疗法
- 神经激肽 3 (NK3)
- 受体拮抗剂
- 选择性血清素
- 再回收抑制剂（SSRI）
- 其他的
- 其他的
6. 全球更年期治疗市场（依给药途径划分），2020 年至 2032 年
- 口服
- 外用
- 肠外
- 阴道
- 其他的
7. 2020 年至 2032 年全球更年期治疗市场（以剂型划分）
- 锭剂
- 奶油
- 修补
- 子宫托
- 注射
- 其他的
8. 全球更年期治疗市场（依适应症划分），2020 年至 2032 年
- 停经
- 闭经
- 停经后
9. 2020 年至 2032 年全球更年期治疗市场（依通路划分）
- 医院药房
- 零售药局
- 网路药局
- 专卖店
- 其他的
第 10 章。 2020 年至 2032 年按地区分類的全球更年期治疗市场
- 北美洲
- 欧洲
- 亚太地区
- 拉丁美洲
- 中东
- 非洲
第十一章竞争格局
- 公司简介
- Novartis AG
- Pfizer Inc.
- Bayer AG
- Teva Pharmaceutical Industries Ltd.
- AbbVie Inc.
- Novo Nordisk A/S
- illendo Therapeutics, Inc.
- Mithra Pharmaceuticals
- Merck &Co., Inc
- Cipla Inc.
- Abbott
- Viatris Inc.
- Organon
- SnapNurse
- Glenmark Pharmaceuticals Limited
- Procter &Gamble
- Duchesnay USA.
- TherapeuticsMD, Inc.
- Avion Pharmaceuticals
- KWS
- PharmaCare Europe Ltd.
- Amneal Pharmaceuticals LLC.
第十二章 章节
- 参考
- 调查方法
- 关于出版商
简介目录
Product Code: CMI6676
Global Menopause Treatment Market is estimated to be valued at USD 15.23 Bn in 2025 and is expected to reach USD 23.05 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.1% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 15.23 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 6.10% | 2032 Value Projection: | USD 23.05 Bn |
Figure. Global Menopause Treatment Market Share (%), By Region 2025
Menopause is a natural biological process that usually occurs between the ages of 45 to 55 years in women. It marks the end of a woman's reproductive years and the transition into her post-reproductive life. Some of the most common signs and symptoms of menopause include irregular menstrual periods, hot flashes, night sweats, vaginal dryness, mood changes, and difficulty sleeping. As menopause progresses, a woman's estrogen levels drop dramatically, which could lead to several long-term health risks if left untreated. Therefore, managing symptoms during this transitional phase has become a priority for many women. The global menopause treatment market offers a variety of treatment options for women suffering from menopause symptoms.
Market Dynamics:
The rising prevalence of menopause issues among women owing to changing lifestyle patterns and growing health awareness levels is a key factor driving the growth of global menopause treatment market. Numerous researches have shown that approximately one-fourth of women within the age group of 40 to 60 years report experiencing at least one problematic symptom associated with menopause. There is also the emergence of sedentary jobs and a lack of physical activity, which has escalated the risks of premature or early menopause. Additionally, new product approvals and launches by leading pharmaceutical players are expanding the treatment choices for addressing vasomotor symptoms during menopause. However, side effects associated with hormone replacement therapy and the availability of alternative treatment options still limit the market potential to a certain extent. Moreover, a lack of awareness about treatment in developing nations poses a challenge to market players. Nonetheless, technological advancements in menopausal care and growing medical tourism in the Asia Pacific region are expected to unlock lucrative opportunities for stakeholders in coming years.
Key Features of the Study:
- This report provides an in-depth analysis of the global menopause treatment market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2025-2032), considering 2024 as the base year
- It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global menopause treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Novartis AG, Pfizer Inc., Bayer AG, Teva Pharmaceutical Industries Ltd., AbbVie Inc., Novo Nordisk A/S, illendo Therapeutics, Inc., Mithra Pharmaceuticals, Merck & Co., Inc, Cipla Inc., Abbott, Viatris Inc., Organon, SnapNurse, Glenmark Pharmaceuticals Limited, Procter & Gamble, Duchesnay USA., TherapeuticsMD, Inc., Avion Pharmaceuticals, KWS, PharmaCare Europe Ltd., Amneal Pharmaceuticals LLC.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global menopause treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global menopause treatment market
Detailed Segmentation:
- Global Menopause Treatment Market, By Treatment Type
- Hormone Therapy
- Estrogen-based Drugs
- Progestin-based Drugs
- Combination Drugs (Estrogen and Progestin, Estrogen and Other Medicines)
- Non-hormonal Therapy
- Neurokinin 3 (NK3)
- Receptor Antagonist
- Selective Serotonin
- Reuptake Inhibitor (SSRI)
- Others
- Others
- Global Menopause Treatment Market, By Route of Administration
- Oral
- Topical
- Parenteral
- Vaginal
- Others
- Global Menopause Treatment Market, By Form
- Tablets
- Creams
- Patches
- Pessaries
- Injections
- Others
- Global Menopause Treatment Market, By Indication
- Perimenopause
- Menopause
- Postmenopause
- Global Menopause Treatment Market, By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Specialty Stores
- Others
- Global Menopause Treatment Market, By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
- Company Profiles
- Novartis AG
- Pfizer Inc.
- Bayer AG
- Teva Pharmaceutical Industries Ltd.
- AbbVie Inc.
- Novo Nordisk A/S
- illendo Therapeutics, Inc.
- Mithra Pharmaceuticals
- Merck & Co., Inc
- Cipla Inc.
- Abbott
- Viatris Inc.
- Organon
- Glenmark Pharmaceuticals Limited
- Procter & Gamble
- Duchesnay USA.
- TherapeuticsMD, Inc.
- Avion Pharmaceuticals
- KWS
- PharmaCare Europe Ltd.
- Amneal Pharmaceuticals LLC.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Treatment Type
- Market Snippet, By Route of Administration
- Market Snippet, By Form
- Market Snippet, By Indication
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- New Product Launches
- Rising Geriatric Population
- Financial Support Through Funding And Investments
- Impact Analysis
- Key Highlights
- Market Trends
- PEST Analysis
- Regulatory Scenario
- Mergers, Acquisitions, and Collaborations
- Key Services Offered
- Treatment cost Analysis
- Identification of Top Market Players
- Government Initiatives and Investments
- Brand Mapping & Pricing Analysis
- Healthcare Spending by Country
4. Global Menopause Treatment Market - Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
5. Global Menopause Treatment Market, By Treatment Type, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hormone Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Estrogen-based Drugs
- Progestin-based Drugs
- Combination Drugs (Estrogen and Progestin, Estrogen and Other Medicines)
- Non-hormonal Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Neurokinin 3 (NK3)
- Receptor Antagonist
- Selective Serotonin
- Reuptake Inhibitor (SSRI)
- Others
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
6. Global Menopause Treatment Market, By Route of Administration, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Vaginal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
7. Global Menopause Treatment Market, By Form, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Tablets
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Creams
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Patches
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Pessaries
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Injections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
8. Global Menopause Treatment Market, By Indication, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Perimenopause
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Menopause
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Postmenopause
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
9. Global Menopause Treatment Market, By Distribution Channel, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Specialty Stores
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
10. Global Menopause Treatment Market, By Region, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, By Region/Country, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region/Country, 2021 - 2032
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Form, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Form, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Form, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Form, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Form, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Form, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Bn)
- North Africa
- Central Africa
- South Africa
11. Competitive Landscape
- Company Profile
- Novartis AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Pfizer Inc.
- Bayer AG
- Teva Pharmaceutical Industries Ltd.
- AbbVie Inc.
- Novo Nordisk A/S
- illendo Therapeutics, Inc.
- Mithra Pharmaceuticals
- Merck & Co., Inc
- Cipla Inc.
- Abbott
- Viatris Inc.
- Organon
- SnapNurse
- Glenmark Pharmaceuticals Limited
- Procter & Gamble
- Duchesnay USA.
- TherapeuticsMD, Inc.
- Avion Pharmaceuticals
- KWS
- PharmaCare Europe Ltd.
- Amneal Pharmaceuticals LLC.
- Analyst Views
12. Section
- References
- Research Methodology
- About us
